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BACKGROUND: Parity has been linked to gallbladder cancer and gallstones, but the effects of other reproductive factors are less clear.
METHODS:We examined 361 incident biliary tract cancer cases, 647 biliary stone cases, and 586 healthy women in a population-based
study in Shanghai.
RESULTS: The effects of parity (odds ratios, ORX3 vs 1 child¼2.0, 95% confidence interval (CI) 0.7–5.1), younger age at first birth
(ORper 1-year decrease¼1.2, 95% CI 0.99–1.6), and older age at menarche (ORper 1-year increase¼1.4, 95% CI 1.1–1.8) on gallbladder
cancer risk were more pronounced among women with stones, but the interactions were not significant.
CONCLUSION: Our results provide support for high parity, younger age at first birth, and late age at menarche in the development
of gallbladder cancer, particularly among women with biliary stones.
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Biliary tract cancers, encompassing tumours of the gallbladder,
extrahepatic bile ducts, and ampulla of Vater, are uncommon but
highly fatal (Hsing et al, 2006). Apart from a strong association
with gallstones, little is known about the aetiology of these cancers
(Lowenfels et al, 1989; Hsing et al, 1998, 2006). The incidence
rates for gallbladder cancer and gallstones are two-fold higher
in women, whereas bile duct and ampulla of Vater cancers are
50% more common in men (Hsing et al, 2006), suggesting
that reproductive and/or hormonal factors have a role in their
pathogenesis (Sama et al, 1990; Vitetta et al, 2000).
High parity is considered as a risk factor for gallstones (Thijs
et al, 1991; Stampfer et al, 1992). During pregnancy, gallbladder
volume increases and the flow of bile decreases, which are
precursors to gallstone formation (Everson et al, 1982, 1991).
Moreover, elevated oestrogen levels during pregnancy increase
cholesterol content in the bile, contributing to biliary stasis
(Braverman et al, 1980; Kern et al, 1982; Everson et al, 1982, 1991;
Novacek, 2006). Pregnancy has also been associated with
gallbladder cancer (Lambe et al, 1993; LaVecchia et al, 1993;
Moerman et al, 1994; Tavani et al, 1996), but the modifying effect
of gallstones and the role of other reproductive factors are not
clear. We examined the risks of biliary tract cancers and stones
associated with several reproductive factors among women in a
population-based case–control study in Shanghai, China, where
the rates of these conditions have rapidly increased in recent
decades (Hsing et al, 2006, 1998).
MATERIAL AND METHODS
Details of the study have been described previously (Hsing et al,
2007a,b,c,d; Andreotti et al, 2008; Hsing et al, 2008). A total of
361 women with biliary tract cancer (269 gallbladder, 92 bile duct)
between 35 and 74 years of age were included. Ampulla of Vater
cancer cases were excluded because of small numbers (n¼31).
In all, 70% of cancer cases were confirmed by histopathology,
whereas the remaining were confirmed with medical records. We
included 647 female patients with stones (511 gallstones, 136 bile
duct stones) but without cancer; stone cases were confirmed with
medical records. A total of 586 healthy women without cancer or
stones were randomly selected from the Shanghai population.
Stone status was assessed in nearly all cancer cases and controls
using self-reported history and medical records.
Information on demographic, lifestyle, and reproductive factors
was obtained through in-person interviews. Cancer and stone cases
were interviewed within 3 weeks after diagnosis. Response rates
were 95% among cases and 82% among controls. A second
interview was conducted 3 months later among 5% of the subjects;
the concordance of responses was 90%.
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cholecystectomy (n¼545), bile duct cancers with all controls
(n¼586), and stones with controls without stones (n¼422). Odds
ratios (ORs) and 95% confidence intervals (CIs) were calculated
using unconditional logistic regression adjusted for age, education,
and body mass index. Continuous variables were categorised into
quartiles or tertiles on the basis of distributions within controls
and those reported among Chinese women (Gao et al, 2000;
Wernli et al, 2006). The likelihood ratio test was used to test for
multiplicative interactions.
RESULTS
Of the biliary diseases examined, the strongest associations were
for gallbladder cancer after adjustment for age, education, and
body mass index (Table 1). Parity was positively associated with
gallbladder cancer (P-trend¼0.04). Compared with women who
had one child, those having three or more children had a 2.1-fold
risk (95% CI 1.0–4.2) of gallbladder cancer. Among parous women
(97% of subjects), those who had their first child before 27 years of
age had higher risks of gallbladder cancer relative to those who had
their first child at 27 years or after, although the trend test was not
significant (P-trend¼0.15). Women who began menstruating after
the age of 17 years had a 1.8-fold risk (95% CI 1.03–3.24) of
gallbladder cancer, compared with those with menarche at age 13
years or younger, but the trend test was borderline significant
(P-trend¼0.05). Breastfeeding was associated with a reduced risk
of bile duct cancer (OR¼0.40, 95% CI 0.20–0.81), but the
association became borderline significant after adjustment for
parity (OR¼0.90, 95% CI 0.74–1.00). Parity was not associated
Table 1 Odds ratios (ORs) and 95% confidence intervals (CIs) for biliary stones and biliary tract cancers in relation to reproductive factors
Biliary stones Gallbladder cancer Bile duct cancer
Controls
a Cases
a OR
b (95% CI)
b P-value
b Controls
c Cases
c OR
b (95% CI)
b P-value
b Controls
d Cases
d OR
b (95% CI)
b P-value
b
Total 422 647 — — 545 269 — — 586 92 — —
Parity
0 11 28 2.59 (0.99–6.79) 16 4 0.77 (0.20–2.99) 18 4 0.98 (0.23–4.25)
1 67 174 1 Reference 80 26 1 Reference 81 12 1 Reference
2 104 147 0.77 (0.50–1.21) 124 43 1.15 (0.63–2.12) 132 22 1 (0.46–2.20)
3 70 113 1.11 (0.65–1.91) 103 52 1.60 (0.83–3.12) 111 23 1.07 (0.46–2.50)
4 64 77 0.91 (0.50–1.66) 85 58 2.20 (1.09–4.47) 93 12 0.61 (0.23–1.65)
5 50 54 0.80 (0.42–1.55) 67 46 2.20 (1.01–4.66) 73 7 0.43 (0.14–1.34)
X6 56 53 0.79 (0.40–1.56) 70 39 1.70 (0.75–3.74) 78 12 0.68 (0.23–1.98)
P-trend
e 0.63 0.04 0.14
Age at first birth (years)
f
X27 112 193 1 Reference 144 45 1 Reference 150 19 1 Reference
24–26 84 155 1.31 (0.89–1.92) 105 49 1.51 (0.92–2.48) 112 22 1.48 (0.75–2.90)
21–23 100 129 1.13 (0.74–1.70) 128 83 1.85 (1.14–2.99) 142 25 1.22 (0.60–2.46)
p20 115 141 1.10 (0.72–1.67) 151 87 1.48 (0.90–2.42) 163 22 0.91 (0.43–1.92)
P-trend
e 0.82 0.15 0.66
Age at menarche (years)
p13 79 136 1 Reference 110 31 1 Reference 115 16 1 Reference
14–15 149 244 1.05 (0.73–1.51) 193 98 1.75 (1.09–2.82) 208 38 1.26 (0.67–2.37)
16–17 136 195 0.95 (0.65–1.39) 170 95 1.80 (1.11–2.92) 184 23 0.89 (0.45–1.78)
X18 58 70 0.89 (0.55–1.43) 72 41 1.82 (1.03–3.24) 79 14 1.22 (0.55–2.72)
P-trend
e 0.52 0.05 0.95
Menopause status
Postmenopausal 381 518 1 Reference 500 245 1 Reference 540 85 1 Reference
Premenopausal 39 126 0.90 (0.51–1.60) 0.72 43 20 1.19 (0.53–2.66) 0.68 44 3 0.29 (0.07–1.23) 0.09
Age at menopause (years)
g
p46 84 139 1 Reference 107 55 1 Reference 116 20 1 Reference
47–49 113 148 0.78 (0.53–1.14) 158 83 1 (0.65–1.53) 173 25 0.78 (0.41–1.48)
50–52 120 160 0.81 (0.57–1.17) 152 76 0.96 (0.62–1.48) 164 28 0.95 (0.51–1.79)
X53 64 71 0.63 (0.40–0.99) 83 31 0.70 (0.41–1.20) 87 12 0.78 (0.36–1.69)
P-trend
e 0.05 0.20 0.96
Lifetime duration of menstruation (years)
g,h
p29 138 184 1 Reference 178 107 1 Reference 195 31 1 Reference
30–32 111 143 0.92 (0.65–1.30) 149 63 0.71 (0.48–1.04) 159 19 0.68 (0.37–1.27)
X33 132 191 0.95 (0.68–1.32) 173 74 0.79 (0.54–1.16) 186 35 1.14 (0.67–1.97)
P-trend
e 0.47 0.09 0.68
Ever used oral contraceptives
No 268 384 1 Reference 343 165 1 Reference 372 49 1 Reference
Yes 68 110 1.09 (0.76–1.55) 0.64 84 35 0.87 (0.55–1.38) 0.54 91 19 1.62 (0.90–2.91) 0.11
Breastfeeding
f
Never 28 76 1 Reference 39 22 1 Reference 41 13 1 Reference
Ever 383 542 0.65 (0.40–1.06) 0.08 490 242 0.73 (0.41–1.30) 0.29 527 75 0.40 (0.20–0.81) 0.01
aBiliary stone cases include gallstone and bile duct stones. Biliary stone cases compared with controls without biliary stones (n¼422).
bAdjusted for age (continuous), education
and body mass index.
cGallbladder cancer cases compared with population controls with a gallbladder (n¼545).
dBile duct cancer cases compared with all population controls
(n¼586).
eLinear test of trend using continuous variable.
fAmong women with at least one full-term birth (n¼568 controls).
gDuration of menstruation¼Age at menopause–
age at menarche–years of pregnancy.
hAmong postmenopausal women (n¼540 controls).
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age at stone diagnosis (o50 years, X50 years), or duration
between diagnosis and interview (o1 year, 1–4 years, 5–9 years,
X10 years). None of the other reproductive factors were associated
with biliary stones, and there was no effect of menopausal status,
age at menopause, or menstruation duration on the risk of biliary
tract cancer.
The effects of parity, age at first birth, and age at menarche
on gallbladder cancer risk were more pronounced among women
with stones, but the interactions were not statistically significant
(Table 2). Among women with stones, parity (X3 vs 1 child)
was associated with a 1.9-fold risk (95% CI 0.74–5.09), whereas
those without stones had a 1.2-fold risk (95% CI 0.25–5.84)
(P-interaction¼0.09). Among women with stones, the effect of parity
was attenuated after further adju s t m e n tf o ra g ea tf i r s tb i r t ha n d
age at menarche (ORX3 vs 1c h i l d¼1.47, 95% CI 0.51–4.23). Younger
age at first birth (o27 vs X27) was associated with a two-fold risk,
but the estimates did not increase monotonically (P-trend¼
0.06) among those with stones; the association was weaker among
those without stones (P-trend¼0.39) (P-interaction¼0.07).
Among women with stones, the association between age at first
birth and gallbladder cancer was not considerably changed when
further adjusted for parity and age at menarche. Older age at
menarche was significantly associated with gallbladder cancer
among women with stones (ORper 1-year increase¼1.37, 95% CI
1.06–1.77, P-trend¼0.02), but nonsignificantly among women
without stones (ORper 1-year increase¼1.32, 95% CI 0.89–1.96,
P-trend¼0.17) (P-interaction¼0.86). The association between age
at menarche and gallbladder cancer remained significant after
further adjustment for parity and age at first birth, although the
estimates did not increase monotonically.
Given the strong inverse correlation between parity and age at
first birth among controls (r¼ 0.66, Po0.0001), we examined
their joint effect on gallbladder cancer among women with stones
(Table 2). The risk of gallbladder cancer increased monotonically
with increasing parity, regardless of age at first birth, but was
highest for women having four or more children, with the first
birth before the age of 23 years (OR¼3.26, 95% CI 1.06–10.03).
Gallbladder cancer risk also increased monotonically with
increasing parity regardless of age at menarche, but the highest
Table 2 Odds ratios (ORs) and 95% confidence intervals (CIs) for gallbladder cancer in relation to reproductive factors by biliary stone status
Without biliary stones With biliary stones
Reproductive factors Controls
a Cases
a OR
b (95% CI)
b P-value
b Controls
a Cases
a OR
b (95% CI)
b P-value
b OR
c (95% CI)
c P-value
c
Total 422 36 — — 123 233 — —
Parity
01 1 2 — — 5 2 — — — —
1 67 10 1 Reference 13 16 1 Reference 1 Reference
2 104 4 — — 20 39 2.02 (0.77–5.31) 1.77 (0.64–4.87)
3( X3 for no stones) 240 20 1.21 (0.25–5.84) 33 43 1.35 (0.52–3.49) 1.23 (0.44–3.43)
4 — — — — 21 53 2.89 (1.02–8.23) 2.55 (0.81–8.05)
5 — — — — 17 42 2.86 (0.95–8.62) 2.38 (0.69–8.15)
X6 — — — — 14 37 2.99 (0.93–9.65) 2.43 (0.65–9.07)
P-trend
d — — 0.57 — — 0.03 — — 0.16
P-interaction 0.09
Age at first birth (years)
e
X27 112 9 1 Reference 32 36 1 Reference 1 Reference
24–26 84 10 1.83 (0.66–5.06) 21 39 1.77 (0.84–3.71) 1.74 (0.81–3.76)
21–23 100 9 1.21 (0.39–3.82) 28 74 2.56 (1.28–5.13) 2.36 (1.12–4.99)
p20 115 6 0.59 (0.16–2.22) 36 81 1.96 (0.97–3.95) 1.86 (0.84–4.15)
P-trend
d 0.39 0.06 0.13
P-interaction 0.07
Age at menarche (years)
p13 79 5 1 Reference 31 26 1 Reference 1 Reference
14–15 149 11 1.10 (0.35–3.43) 44 87 2.29 (1.20–4.40) 2.20 (1.12–4.29)
16–17 136 12 1.32 (0.43–4.03) 34 83 2.71 (1.37–5.33) 2.60 (1.29–5.24)
X18 58 8 2.33 (0.67–8.14) 14 33 2.61 (1.12–6.09) 2.28 (0.96–5.39)
P-trend
d 0.17 0.02 0.04
P-interaction 0.86
Parity and age at first birth (years)
0–1andX24 — — — — 10 14 1 Reference — —
2–3andX24 — — — — 31 43 1.47 (0.52–4.16) — —
X4 and X24 — — — — 12 18 1.86 (0.49–6.94) — —
0–1andp23 — — — — 2 2 — —
2–3andp23 — — — — 22 39 1.77 (0.59–5.20) — —
X4 and p23 — — — — 40 114 3.26 (1.06–10.03) — —
Parity and age at menarche (years)
0–1andp15 — — — — 12 12 1 Reference — —
2–3andp15 — — — — 37 44 1.48 (0.49–4.40) — —
X4 and p15 — — — — 26 57 3.19 (0.95–10.69) — —
0–1andX16 — — — — 6 6 1.12 (0.21–6.09) — —
2–3andX16 — — — — 16 36 2.56 (0.79–8.21) — —
X4 and X16 — — — — 26 74 4.01 (1.19–13.58) — —
aGallbladder cancer cases compared with population controls with a gallbladder (n¼545).
bAdjusted for age (continuous), education and body mass index.
cFurther adjusted for
age first birth (continuous), age menarche (continuous) and parity; each factor is not self-adjusted.
dLinear test of trend using continuous variable.
eAmong women with at least
one full-term birth (n¼568 controls).
Reproductive factors and biliary tract cancers and stones risks
G Andreotti et al
1187
British Journal of Cancer (2010) 102(7), 1185–1189 & 2010 Cancer Research UK
E
p
i
d
e
m
i
o
l
o
g
yrisk was seen for women having four or more children, with age at
menarche being 16 years or older (OR¼4.01, 95% CI 1.19–13.58).
DISCUSSION
We observed that high parity, early age at first birth, and late age at
menarche contributed to gallbladder cancer risk. It is unclear why
we did not find an association between parity and biliary stones, as
previous studies have shown positive associations (Scragg et al,
1984; Basso et al, 1992), but some have been null (Maclure et al,
1989; Chen et al, 1999; Walcher et al, 2005). We lacked information
on modifying factors, such as pre-pregnancy body mass index,
which may have obscured an association (Basso et al, 1992;
Lindseth and Bird-Baker, 2004; Ko et al, 2005). Of the 230 parous
women with gallbladder cancer and biliary stones, 98% had their
stones diagnosed after giving birth, and 50% 430 years after
giving birth. It is likely that asymptomatic gallstones were present
for many years before diagnosis, as it has been estimated that 20%
of stones become symptomatic after 20 years (Diehl, 1991; Wada
et al, 1993). The mechanism underlying the interaction between
parity and stones in the development of gallbladder cancer is
unclear, but may involve combined or sequential hormonal and
inflammatory effects (Bartlett, 2000; Pandey and Shukla, 2000;
Tazuma and Kajiyama, 2001).
Given the high correlation between parity and age at first birth,
it is difficult to tease apart their individual effects. Among women
with stones, a strong joint effect was evident for parity and early
age at first birth. This finding is biologically plausible, as younger
age at first birth may reflect higher levels and longer exposure to
oestrogen and progesterone (Moerman et al, 1994). Although not
statistically significant, there was a positive correlation between
age at first birth and age of first stone diagnosis among controls,
with mean ages of first stone diagnosis of 50 and 58 years for
women who gave birth before the age of 21 and after 26 years,
respectively.
The association between late age at menarche and gallbladder
cancer is consistent with the results of some previous studies
(Pandey and Shukla, 2003), but not with all (Chow et al, 1994;
Moerman et al, 1994; Tavani et al, 1996; Zatonski et al, 1997). In
our study, the association was independent of stones, parity, and
age at first birth. It is unclear why older age at menarche was
associated with higher gallbladder cancer risk, as younger age at
menarche has been linked to longer exposure to oestrogen and
progesterone (Moerman et al, 1994). As the risk estimates did not
increase monotonically with increasing age at menarche, these
findings should be interpreted with caution.
Breastfeeding was associated with a reduced risk of bile duct
cancer, independent of stones, parity, and age at menarche, but
was not associated with gallbladder cancer. Breastfeeding was
related to a higher risk of gallbladder cancer in a South-American
study (Strom et al, 1995), but not to gallbladder or bile duct cancer
in a Japanese study (Kato et al, 1989). Although breastfeeding may
have an effect through hormonal mechanisms (Bonnar et al, 1975;
Braverman et al, 1980; Kern et al, 1982; Tazuma and Kajiyama,
2001; Novacek, 2006), our finding could be due to chance.
The null effect of menopausal status is consistent with the
results of previous studies (Pandey and Shukla, 2003; Pagliarulo
et al, 2004); however, as the majority of our population was
postmenopausal (92.5% controls), we had limited statistical power
to assess risk among premenopausal women. In addition, the null
effect of oral contraceptive (OC) use is consistent with the results
of previous studies on biliary stones (Pagliarulo et al, 2004;
Dhiman and Chawla, 2006) and biliary tract cancers (Milne and
Vessey, 1991; Chow et al, 1994; Moerman et al, 1994), but the
prevalence of OC use in the population is low (20% controls) and
we lacked information on duration, composition, dose, and age of
use. Furthermore, few subjects received hormone replacement
therapy (2.4% controls), which has been associated with gallstones
(Uhler et al, 2000; Simon et al, 2001; Chen et al, 2006) and
gallbladder cancer (Gallus et al, 2002; Fernandez et al, 2003).
In this study, selection bias was minimal because of the
population-based design, high case ascertainment, and high
response rates. Misclassification of cases was minimal because of
the review of diagnostic data. The assessment of stone status allowed
us to evaluate cancer risk while controlling for stones. The limited
exposure to OCs and hormone-replacement therapy allowed us to
assess reproductive factors independently of exogenous hormones.
Despite being the largest population-based study on biliary tract
cancers to date, we had limited statistical power to test for
interactions. In addition, our findings may have limited generali-
sability because of the homogeneous Shanghai population.
This study revealed increased risks of gallbladder cancer
associated with higher parity, younger age of first birth, and late
age at menarche, primarily among those with stones, whereas there
was no effect for menopausal status or OC use. The joint effects of
reproductive risk factors and stones suggest the need for further
study into the hormonal and inflammatory mechanisms under-
pinning the development of gallbladder cancer.
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